Developmental exposure to estrogenic compounds and obesity
Open accessThe DOI matches its Crossref record.
Abstract
Obesity, defined as excessive body fat (>25% for men; >30% for women), is a significant human health problem that has reached epidemic proportions in the United States over the last 2–3 decades (Oken and Gillman, 2003). Obesity and overweight are not confined to the United States. The World Health Organization has declared excessive weight as 1 of the top 10 health risks in the world, and 1 of the top 5 in developed nations. Obesity and overweight are associated with increased risk of a number of diseases and metabolic disorders including type 2 diabetes, hyperinsulinemia, insulin resistance, coronary heart disease, high blood pressure, stroke, gout, liver disease, asthma and pulmonary problems, gall bladder disease, kidney disease, reproductive problems, psychological and social problems, osteoarthritis, and certain cancers. Obesity is a significant health risk for adults, but it is a far more serious problem for children because the incidence of type 2 diabetes, usually considered an adult-onset disease, is dramatically increasing in children and adolescents along with the rise in obesity. Further, because overweight children have a greater chance of becoming overweight adults, their prospect for good future health is not promising. Obesity, like many other chronic health problems, is caused by a complex interaction between genetic, behavioral, and environmental factors. Commonly held causes of obesity are overeating and a sedentary lifestyle, imposed on a background of genetic predisposition for the disease. Although much interest has focused on these factors, uncertainty still remains as to the etiology of obesity. Another hypothesis that has recently emerged is that in utero and early developmental exposures to environmental chemicals may play a role in the development of obesity later in life. An increasing number of studies report that exposure to chemicals during critical periods of differentiation, at low environmentally relevant doses, alters developmental programming but does not result in malformation or low birth weight, yet still causes increased susceptibility to disease later in life (National Toxicology Program, 2001; Newbold et al., 2004). With regard to obesity, Baillie-Hamilton (2002) postulated a role for chemical toxins in the etiology of obesity and reviewed data showing that the current epidemic of obesity coincides with the marked increase of chemical use in the environment. She cited numerous studies in which chemicals such as pesticides, organophosphates, carbamates, polychlorinated biphenyls, polybrominated biphenyls, phthalates, bisphenol A, heavy metals, and solvents caused weight gain, possibly by interfering with weight homeostasis, such as alterations in weight-controlling hormones, altered sensitivity to neurotransmitters, or altered activity of the sympathetic nervous system (Baillie-Hamilton, 2002). Of interest, some of the chemicals cited in the review were actually intended to increase weight, especially some of those chemicals with "hormone-like" activity. For >20 years, research in our laboratory has focused on the effects of estrogenic compounds on development and differentiation. Our working premise has been that the developing organism is extremely sensitive to perturbation by chemicals with estrogenic or endocrine disrupting activity and that exposure to these chemicals during critical stages of differentiation may have permanent long-lasting consequences, some of which may not be expressed or detected until later in life. Diethylstilbestrol (DES) is a well-known example of such a chemical; thus, we have used DES as a model chemical to study environmental estrogens. DES, a synthetic estrogen, was widely prescribed from the 1940s through the 1970s for the prevention of threatened miscarriage. A range of 2–8 million treated pregnancies worldwide has been estimated. Today it is well recognized that prenatal DES treatment results in a low incidence of neoplasia in the female offspring and a high incidence of benign abnormalities in both the male and female offspring (NIH, 1999). To study the mechanisms involved in the toxicity of DES, we developed an animal model using outbred CD-1 mice treated with DES by subcutaneous injections on GD 9–16 (the period of major organogenesis in the mouse) or days 1–5 of neonatal life (a period of cellular differentiation of the reproductive tract and a critical period of immune and behavioral differentiation). The prenatal DES animal model has successfully duplicated and, in some cases, predicted many of the alterations (structural, function, cellular, and molecular) observed in similarly DES-exposed humans (Newbold, 1995). Although our major focus has been on reproductive tract abnormalities, we also examined the effects of DES on body weight over a wide dose range of exposure. High prenatal DES doses (10–100 μg/kg of maternal body weight) caused a decrease in the offspring's adult body weight; likewise, high neonatal DES doses (1000
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
“This wake-up call led to a new hypothesis: that exposure to environmental chemicals during development may play a role in predisposing to obesity later in life (165, 166).”
BackgroundFemale reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing
Crain, D. A., Janssen, S. J., Edwards, T. M., Heindel, J., Ho, S.-M., Hunt, P., Iguchi, T., Juul, A., McLachlan, J. A., Schwartz, J., et al. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.067 · Cited by 465
The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity
vom Saal, F. S., Nagel, S. C., Coe, B. L., Angle, B. M., & Taylor, J. A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.001 · Cited by 450
Endocrine Disruptors and Obesity
Darbre, P. D. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0240-4 · Cited by 395
Environmental Obesogens: Mechanisms and Controversies
Heindel, J. J., & Blumberg, B. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021304 · Cited by 340
Metadata
- Authors
- Newbold, R. R., Padilla‐Banks, E., Snyder, R. J., & Jefferson, W. N.
- Venue
- Birth Defects Research Part A: Clinical and Molecular Teratology
- Publisher
- Wiley
- Published
- 2005-06-15
- Volume
- 73
- Issue
- 7
- Pages
- 478-480
- ISSN
- 1542-0752 (ISSN-L)
- 1542-0760
- OpenAlex
- W1993811496
- Cited by
- 132
- References
- 0
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Developmental exposure to estrogenic compounds and obesity. https://app.cochat.ai/papers/10.1002/bdra.20147
- The paper
- Newbold, R. R., Padilla‐Banks, E., Snyder, R. J., & Jefferson, W. N. (2005). Developmental exposure to estrogenic compounds and obesity. Birth Defects Research Part A: Clinical and Molecular Teratology. https://doi.org/10.1002/bdra.20147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.